CHA News Article

Drug Enforcement Administration Addresses IV Opioid Shortage

Responding to hospitals’ requests for action on the intravenous opioid shortage, the Drug Enforcement Administration has granted additional quota for raw materials to certain manufacturers so that they can produce needed medications. The Food and Drug Administration has updated its drug shortage database to reflect the upcoming availability of these products from West-Ward Pharmaceuticals and Fresenius Kabi, USA. Both companies have indicated that they will continue to work on additional quota requests to accommodate hospitals’ supply needs.

For more information about how to access these products, see the FDA’s database, which includes customer service contact information for these and other drug companies. In addition, the American Society of Health-System Pharmacists and the University of Utah Drug Information Service have developed a new resource with suggestions for managing the injectable opioid shortages.